Menu

Search the site

Reading comfort

Adjust the site to suit your eyes and energy today. Your choices are saved on this device.

Text size
Colours
Calm mode

Lower contrast, no animation, softer colours. Helpful with light sensitivity or headaches.

Sources & updates

The studies, organisations and news sources behind this site, and where to follow ME/CFS research as it happens.

2 min read Last reviewed 8 November 2026

Where to follow research as it happens

Key sources used on this site

Conference and research summaries

Trial registries (checked 3 November 2026)

Every trial on our trials page links to its official registry entry: ANZCTR, ClinicalTrials.gov, ISRCTN or the EU Clinical Trials Register.

Studies referenced

Every research claim on this site now carries a numbered citation linking to the study, registry entry or official page it comes from. You’ll find the full list at the bottom of each page under References, with the evidence type labelled. The site cites more than 350 sources in total.

The most important include: the US Institute of Medicine report Beyond ME/CFS: Redefining an Illness (2015); the UK NICE guideline NG206 (2021); the DecodeME genetic study (2025 preprint); the Griffith University TRPM3 and glymphatic studies; the Canadian LDN trial (NCT05430152); the ADDRESS-LC bezisterim trial (NCT06847191); the Simmaron rapamycin study; the Charité care-model study (2026); the Castro-Marrero CoQ10 + NADH trials; the RESTORE ME oxaloacetate trial; and the Royal Children’s Hospital Melbourne long-term follow-up of young people.

Spotted something out of date?

Research moves fast, and trial statuses change. Every page shows when it was last reviewed. For the latest status of any trial, always check its official registry link.